PROC 0.85 (-12.37%)
LU2376511205Drug ManufacturersDrug Manufacturers - Specialty & Generic

Procaps Group (PROC) Competitor Comparison

We are evaluating the key criteria listed to compare Procaps Group (PROC) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 5 years - PROC ranking 31 / 54

These are the competitors of Procaps Group in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 5 years
1. Kamada KMDA
584.6
2. Evolus EOLS
70.59
3. Phibro Animal Health PAHC
56.75
4. ProPhase Labs PRPH
32.25
5. ANI Pharmaceuticals ANIP
30.93
6. Green Thumb Industries R9U2.F
27.65
7. Regencell Bioscience Holdings RGC
23.18
8. Alvotech ALVO
13.53
9. Catalent CTLT
13.45
10. Neoleukin Therapeutics NLTX
8.58
11. Alimera Sciences ALIM
7.82
12. Vifor Pharma G2AB.F
7.23
13. PetIQ PETQ
6.43
14. Curaleaf Holdings CURLF
5.39
15. Elanco Animal Health ELAN
4.95
16. Zoetis ZTS
4.89
17. Kolinpharma KIP.MI
4.88
18. Pacira BioSciences PCRX
4.79
19. Perrigo PRGO
4.77
20. Linc LNC
4.68
21. Ironwood Pharmaceuticals IRWD
4.05
22. Ayr Wellness 3KJB.F
3.71
23. Organogenesis Holdings ORGO
3.67
24. Taro Pharmaceutical Industries TARO
3.55
25. Journey Medical DERM
3.19
26. Supernus Pharmaceuticals SUPN
2.98
27. Cronos Group CRON
2.87
28. Emergent BioSolutions EBS
2.86
29. Relmada Therapeutics RLMD
2.79
30. Bausch Health Companies BHC
2.75
31. Procaps Group PROC
2.74
32. Embecta EMBC
2.53
33. Zynerba Pharmaceuticals ZYNE
2.47
34. Cumberland Pharmaceuticals CPIX
2.41
35. Jupiter Wellness JUPW
2.39
36. Solid Biosciences SLDB
2.37
37. Societal CDMO SCTL
2.21
38. Eagle Pharmaceuticals EGRX
2.19
39. Theratechnologies THTX
2.14
40. Alpha Teknova TKNO
1.89
41. SCYNEXIS SCYX
1.89
42. Collegium Pharmaceutical COLL
1.87
43. Clever Leaves Holdings CLVR
1.87
44. OptiNose OPTN
1.83
45. Tilray Brands TLRY
1.79
46. Ascend Wellness Holdings AAWH
1.77
47. Biofrontera BFRI
1.74
48. Flora Growth FLGC
1.63
49. Teva Pharmaceutical Industries TEVA
1.62
50. Universe Pharmaceuticals UPC
1.61
51. Amphastar Pharmaceuticals AMPH
1.18
52. Avadel Pharmaceuticals AVDL
0.8
53. Amneal Pharmaceuticals AMRX
0.75
54. Harrow Health HROW
0.49

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.